1 Followers
25 Following
trendinghealthcarenews

trendinghealthcarenews

Global Opioids Market Size Industry Analysis, Growth, Share Segments, Key Innovative Product Development Strategies, Top Key Players and Future Trends Analysis By 2023

Market Research Future (MRFR) publishes periodic market research report on Opioids Market Information: By Product (Extended-Release/Long-Acting Opioid, Immediate Release/Short Acting Opioid), by Application (Pain Relief, Anesthesia, Cough Suppression, Deaddiction, Others), by End User, and by Region — Global Forecast till 2023

Leading Market Players

Sanofi SA (France), Pfizer Inc. (US), Boehringer Ingelheim GmbH (Germany), Teva Pharmaceutical Industries Ltd (Israel), Allergan Inc. (US), Purdue Pharma L.P. (US), West-Ward Pharmaceuticals Corporation (Jordan), Sun Pharmaceutical Industries Ltd (India), Egalet Corporation (US), Janssen Global Services, LLC (US), Vertice Pharma LLC (UK), Mallinckrodt (Surrey), and others.

Opioids Market Overview

The global opioids market is expected to register a CAGR of 7.12% during the forecast period with a market value of USD 19,554.49 million in 2017. Opioids are a type of narcotic pain medications that are used to treat moderate to severe pain medications. According to the National Health Interview Survey 2017, 25.3 million Americans suffer from chronic pain daily and 23.4 million people reported their pain as severe.

Segmentation Analysis

The global opioids market, by product, has been segmented into extended-release/long-acting opioids and immediate-release/short-acting opioids. The extended-release opioid segment is further segmented into oxycodone, oxymorphone, morphine, hydromorphone, and others. The extended-release opioid segment accounted for a value of USD 12,750.91 million in 2017. The immediate-release opioid segment is further segmented into codeine, hydrocodone, fentanyl, morphine, and others. The market, by application, can be segmented into pain relief, anesthesia, cough suppression, diarrhea suppression, and de-addiction. On the basis of end user, the global opioids market is segmented into hospitals & clinics, pharmacies, and academic research institutes.

Table of Content

4 Market Dynamics

4.1 Introduction

 

4.2 Drivers

4.2.1 Increasing Use Of Opioids For Disease Condition Causing Chronic Pains Such As Cancers, Arthritis, Lower Back Pain, And Fibromyalgia

4.2.2 Favorable Reimbursement Policies For Palliative Care In Developed Regions

4.2.3 Substantial Rise In Road Accidents, Trauma, And Surgical Procedures

4.3 Restraints

4.3.1 Rising Addiction And Death Cases Due To Overdose Of Opioid 26

4.4 Opportunities

4.4.1 Reconsideration Of Prescribing Opioid Analgesics Due To Rising Awareness About Opioids Misuse, Abuse, And Overdose Has Prompted Many Stakeholders

List of Tables

TABLE 1 MARKET SYNOPSIS

TABLE 2 PRIMARY INTERVIEWS

TABLE 3 GLOBAL OPIOIDS MARKET, BY PRODUCT, 2015–2023 (USD MILLION)

TABLE 4 GLOBAL OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY REGION, 2015–2023 (USD MILLION)

TABLE 5 GLOBAL OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2015–2023 (USD MILLION)

Continued…

COLLECT DETAILED INFORMATION OF THE REPORT @ https://www.marketresearchfuture.com/reports/opioids-market-7626

Intended Audience

  • Pharmaceutical Companies
  • Research Institutes
  • Hospitals
  • Academic Institutes

This research report provides insights, on various levels of analysis such as industry analysis, market share analysis, leading market players, and their profiles. This report also helps in studying the target segments by providing views on emerging and high-growth segments and market conclusion. Together the market data comprises and discusses basic assessments on the competitive scenarios and strategies of the global opioids market.

Related News

Sex Cord Gonadal Stromal Tumor Market

 

Bariatric Surgery Devices Market

 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

https://www.marketresearchfuture.com/

Biopharmaceuticals Market Trends Analysis, Upcoming Trends, Emerging Growth, Key Players Segments and Forecast to 2023

Biopharmaceuticals Market Research Report - Global Forecast till 2025 Highlights

According to MRFR analysis, Biopharmaceuticals Market is expected to register a CAGR of 8.99% during the forecast period of 2019 to 2025 and was valued at USD 238,192.7 million in 2018.

Biopharmaceuticals are also known as biological, medical products, or biologics, are pharmaceutical drugs manufactured, extracted, or synthesized using biological sources, such as bacteria, yeast, and mammalian cells.

The global biopharmaceuticals market is growing owing to various factors such as increasing investment by major companies on research & development of biopharmaceuticals and increasing acceptance for biopharmaceuticals due to their ability to treat the previously untreatable diseases. Furthermore, the number of geriatric populations is, tremendously, the incidence rate of chronic diseases is also high, and technological advancements are growing which are also expected to fuel the market growth. However, the entry of low-cost biosimilars, risk of side effects that can occur due to high usage of biopharmaceuticals, and stringent government regulations are expected to pose as restraints to the growth of the global biopharmaceuticals market.

Segmentation

The global biopharmaceuticals market has been segmented based on product type and application.

The global biopharmaceuticals market has been segmented, on the basis of product type, into monoclonal antibodies, recombinant growth factors, purified proteins, recombinant proteins, recombinant hormones, vaccines, synthetic immunomodulators, and others. The recombinant growth factors has been further bifurcated into erythropoietin and granulocyte colony-stimulating factor. The purified proteins segment has been further classified as leukemia inhibitory factor (LIF), P53 protein, P38 protein, and others. The recombinant proteins segment has been further divided into serum albumin, amyloid protein, defensin, transferrin, and others. Vaccines have also been segregated into recombinant vaccines, conventional vaccines, and others. The recombinant vaccines have been further sub-segmented into cancer vaccines, malaria vaccines, Ebola vaccines, hepatitis B vaccines, tetanus vaccines, diphtheria vaccines, cholera vaccines, and others. Conventional vaccines have been categorized as polio vaccines, pox vaccines, and others. Synthetic immunomodulators segment has been further divided into cytokines, interferons, interleukins, tumor necrosis factor (TNF), and others. Monoclonal antibodies segment is anticipated to hold the largest market share in the global biopharmaceutical market due to the increasing number of research activities that are supported by the usage of monoclonal antibodies. Vaccines are expected to grow at the fastest CAGR owing to the rising awareness of chronic diseases.

Key Players

Some of the key players in the Global Biopharmaceuticals Market are Pfizer Inc. (US), Amgen Inc. (US), Eli Lilly and Company (US), F. Hoffmann-La Roche Ltd (Switzerland), Johnson & Johnson (US), Gilead Sciences, Inc. (US), AstraZeneca (UK), Abbvie Inc. (US), Sanofi (France), Bristol-Myers Squibb Company (US), Sandoz International GmbH (Germany), Novo Nordisk A/S (Denmark), GlaxoSmithKline PLC (UK), Merck KGaA (Germany), and Biocon (India).

get full report @https://www.marketresearchfuture.com/reports/biopharmaceuticals-market-8439

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is expected to be the largest market owing to the increasing prevalence of chronic diseases. The biopharmaceuticals market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European biopharmaceuticals market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The biopharmaceuticals market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the increasing patient pool suffering from various chronic diseases and a supportive regulatory framework, the market in Asia-Pacific is expected to be the fastest-growing. The biopharmaceuticals market in the Middle East & Africa has been divided into the Middle East and Africa

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is expected to be the largest market owing to the increasing prevalence of chronic diseases. The biopharmaceuticals market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European biopharmaceuticals market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The biopharmaceuticals market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the increasing patient pool suffering from various chronic diseases and a supportive regulatory framework, the market in Asia-Pacific is expected to be the fastest-growing. The biopharmaceuticals market in the Middle East & Africa has been divided into the Middle East and Africa.

Global Bionic Eye Market Size Analysis, Industry Growth Overview, Worldwide Companies Market

Leading Market Manufacturers

Retina Implant AG (Germany), Second Sight (US), Bionic Vision Australia (Australia), The Bionic Eye (UK), Pixium Vision (France), iBionics (Canada)

Market Research Future is the Leading Brand in The Research Company Recently Published Bionic Eye Market Research Reports which includes Study of growth, Regional Analysis, Growth Factors, Top Industry Players Formation Details for Business Development, Major Drivers, Upcoming Trends and Forecast to 2023. Bionic Eye Global Market Prognosticated to Perceive Value Accretions with A Significant CAGR

Bionic Eye Market Overview

Bionic eyes have revolutionized the vision impairment ailment in such a manner that has created immense scope for treating vision related defects. Bionic Eye referred as visual prosthetic has proven to be a boon for the people who have lost their eye-sight. As it offers them with a prosthetic eye that surely compensates functioning as well as before. Although traumatic injuries like traffic accidents, Cancer, Birth defects and diabetes have been the risk factors people are losing their eye sights to; Wartime is also a prominent factor that can cause grievous eye injuries.

Market Research Future which researches and publishes report linked to the healthcare sector along with published reports on other sectors, recently issued a report with findings of this particular industry. The market for bionic eye industry is expanding with a CAGR of 9.8 percent during the forecast period.

Bionic Eye Industry Segments

By Types : Comprises – External Eye (Retinal Prosthesis & MIVP (microsystem-based visual prosthesis) and Implanted Eye.

By Technology : Electronic & Mechanical.

By End Users : Comprises - Hospitals, Clinics, and other.

By Region : Europe, North America, APAC and Rest of the World.

Regional Analysis

The North American region controls the bionic eye industry globally. The advances in technology and increasing number of people suffering from eye-sight problem owing to the growing prevalence of diabetes has fueled the development of the industry. The European region controls the second biggest market for bionic eye which is followed by the Asia Pacific region.

Brows Full Research Report At https://www.marketresearchfuture.com/reports/bionic-eye-market-1261

Industry/ Innovation/ Related News

March 13, 2018 - Pixium Vision (France) leading global player developing “bionic vision” systems reported successful activations of its miniature wireless photovoltaic sub-retinal implant – ‘Prima’. Prima system tried on three Atrophic Dry-AMD patients showed positive reactions.

Related news

Stem Cell Banking Market Research Report - Global Forecast till 2025

 

Vitiligo Treatment Market Research Report - Global Forecast till 2025

 

About Market Research Future:

MRFR team has supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country-level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:

www.marketresearchfuture.com

Infusion Pump Market Size Worth USD 9.71 Billion | CAGR 5% By 2023

Infusion Pump Market Share, Trends And Growth Analysis By Type (Volumetric Pump, Syringe Pump, & Others), By Application (Chemotherapy, Diabetes, Gastrointestinal Diseases, Pediatrics & Others), By End User (Hospitals, Ambulatory Surgical Centers, Homecare & Others) - Forecast To 2023

Rising investments in R&D by the leading market players to bring about further innovations and advancements in their existing product range drive the growth of the infusion pump market. Conversely, patient safety concerns, and improper infusion leading to the severe consequences are factors impeding the growth of the market. Moreover, unmet medical needs in underdeveloped countries would act as an obstacle to market growth.

The Global Infusion Pump Market size is anticipated to reach USD 9.71 billion with expanding at a CAGR of 5% throughout the forecast period (2017-2023). Rising use of infusion pump for drug delivery and high requirement of infusion systems in the military medical units predominantly propel the growth of the Infusion Pump Market. The Infusion pump market size to witness significant growth due to growth in the burgeoning healthcare sector and increasing occurrences of fatal & chronic diseases, globally. Moreover, rising awareness and concerns related to health are some of the factors escalating the market at a global level.

 

Nevertheless, advanced infusion systems would support market growth, increasingly allowing hospitals to make the most of the required expertise. These improved systems would also enable greater participation throughout the infusion process. As medical records become more automated, infusion pumps are too expected to grow increasingly automated. Moreover, as electronic medical records and smart pumps penetrate deeply into the developed markets such as the US and Europe, the infusion pump market value is expected to increase further.

 

 Global Infusion Pump Market Segmentation

The global infusion pump market has been segmented based on

  • Types
  • Application
  • End-user
  • Regions

Based on Types, the global market has been segmented into

  • Volumetric Pump
  • Syringe Pump
  • Ambulatory Pump
  • others

Based on Application, the global market has been segmented into

  • Chemotherapy
  • Diabetes
  • Gastrointestinal Diseases
  • Pediatrics
  • Other

Based on End-user, the global market has been segmented into

  • Hospitals
  • Ambulatory Surgical Centers
  • Homecare
  • Others

Infusion Pump Market Regional Analysis

Based on the geographical distribution, the Global infusion pump market is split among the regions of

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa

North America infusion pump market size is expected to reach USD 3.49 Billion by 2023. North America leads the largest infusion pump market share globally. In the region, advancements in technologies are continuously on the rise. Besides, the high prevalence of diabetes and high healthcare expenditures are fostering regional market growth. The US and Canada, heading with a large number of diabetic population and increasing aging population account for the growth contributors to the regional market. Additionally, the presence of well-established healthcare sector and key players substantiate the growth of the regional market.  Rising with the augmenting market demand,

The European infusion pump market share would reach nearly USD 3.11 billion by the end of the forecast period.  The infusion pump market in the European region is another lucrative market on the global platform. Increasing uptake of infusion pumps for the treatments of rising numbers of diabetic population and focus on using stem cell-derived human islets as a possible cure for type 1 diabetes, drive the regional market growth, commutatively. Besides, availability of funds from the public and private bodies to drive the research and development activities in biotechnology are expected to boost the market growth in the region.

The Asia Pacific infusion pump market size is estimated to register a CAGR of 5.4% throughout the assessment period (2017-2023). The region Factors, such as the presence of proliferating healthcare sector and the improving economy and disposable income per individual are substantiating the growth of the regional market.

Global Infusion Pump Market Competitive Landscape:

Fiercely competitive, the infusion pump market appears to be highly fragmented, characterized by the presence of several well-established players. These players increasingly seek a substantially large revenue and market expansion through various strategic initiatives, such as mergers & acquisitions, collaboration, and product launch. They also invest colossally in research & development activities to innovate and develop a cost-effective product portfolio.

Players operating in the infusion pump markets are increasingly focusing on optimizing situational awareness for customers to ensure their mission success. They possess state-of-art developing labs and strong sales & distribution network, which can help them to gain a leadership position in the market.

Major Players:

Players leading the global infusion pump market, include B. BRAUN MELSUNGEN AG, 3M, Baxter, Fresenius Kabi AG, Becton, Dickinson and Company, ICU Medical, Inc, Terumo Medical Corporation, Zyno Medical and Smiths Medical, among others.

Drivers and Impact:

  • Growing Demand from Key Applications and Potential Industries
  • Rising Demand from Key Regions
  • Intensity of Rivalry
  • Infusion Pump Market Challenges and Impact
  • Infusion Pump Market Trends and Key Opportunities

Browse Full Research Report At: https://www.marketresearchfuture.com/reports/infusion-pumps-market-1509

Industry/ Innovation/ Related News

August 29, 2019 – Eitan Group (Israel), a global leader in advanced infusion therapy solutions across the care continuum, announced its partnership with InfuSystem Holdings, Inc. (INFU – the US), a leading provider of infusion pumps & related services for the healthcare industry in North America. The companies would work together to offer improved repair services to Eitan Group’s suite of infusion systems, including its flagship Sapphire infusion system. The partnership deal is expected to significantly shorten the time it takes to repair Sapphire Infusion Pumps while reducing costs to the end-user at the same time.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services.

 https://www.marketresearchfuture.com

Leprosy Treatment Market Analysis Devices, By Top Key Players, Global Industry Size, Growth Opportunity, Latest Trends and Advanced Technologies To 2023

Leprosy Treatment Market– Overview

Leprosy is one of the diseases that had transformed societies following its outbreak, but after major efforts to eradicate this disease, the detection rates have fallen immensely. Market reports connected with the healthcare industry have been made available by Market Research Future which generates reports on other business verticals that outlines the current market scenarios. The Leprosy Treatment Marketis expected to achieve $ 3.5 billion while progressing at a CAGR of 3.2 % through the forecast period.

The stigma related to the disease had caused significant hurdles in the treatment of leprosy, but a better awareness of the symptoms of the disease has led to the development of the market. Improved detection techniques are expected to further aid the development of the market in the forecast period.

  Leprosy Treatment Market – Key Players: 

The competitors shaping the leprosy treatment market are –

Systopic Laboratories Pvt. Ltd.

Cadila Pharmaceuticals

Novartis International AG

Acme Pharmaceuticals

Macleods Pharmaceuticals

Glaxo SmithKline

Astra Zeneca

Lark Laboratories Ltd. `

Segmental Analysis

The leprosy treatment market is segmented on the basis of disease type, drug class, and market channel. On the basis of drug class, the leprosy treatment market has been segmented into phenazine, sulfone, derivative, anti-tubercular drugs and others. On the basis of disease type, the market has been segmented into multibacillary leprosy and paucibacillary leprosy. On the basis of end users, the market has been segmented into contract, private, and others. The regions included in the market segmentation are Middle East, North America, Asia Pacific, Europe, Africa and the rest of the world.

Detailed Regional Analysis

The regional analysis of the leprosy treatment market covers regions such as the Middle East, North America, Asia Pacific, Europe, Africa and rest of the world. In the North American region, the US is responsible for the maximum market share owing to the favorable reimbursement scenario and increased expenditure on healthcare. The rapid market uptake of new technology in the US is also an essential driver of the market for leprosy treatment. The European region is the next biggest market owing to the availability of large disposable income and improving awareness. The Asia Pacific region is anticipated to have the most potential and it is expected to be led by nations such as China and India. The Middle East & Africa market is controlled by the Gulf nations especially Saudi Arabia and UAE. The poor regions of Africa are anticipated to witness restricted growth due to slow economic and political conditions and restricted healthcare penetration.

Competitive Analysis

The use of effective strategy execution techniques is expected to bear optimistically on the future growth of the Leprosy Treatment Market. The competitors in the market are attempting to establish various leaderships that will enable them to capture a more significant share of the market. Improved accessibility to diverse resources and capabilities is expected to impel the growth of the market in the coming forecast period. Moreover, the vertical integrations and product strategies of the market is increasing the prospects for the market players. The analysis of the market reveals that it is poised for a high growth rate in the forthcoming years. Product differentiation has created a favorable product differentiation scenario that is complementing the market’s growth.

get full report @ https://www.marketresearchfuture.com/reports/leprosy-treatment-market-3862

Industry Updates

Mar 2018 In a recent study by Flavio Alves Lara of the Oswaldo Cruz Institute and colleagues has for the first time characterized blood clots that help in detecting leprosy at an early stage. Their findings lead to a new understanding of how leprosy affects the circulatory system but also to possible new screening tests to detect leprosy sooner. Lara and colleagues had searched for blood clotting abnormalities among 638 leprosy patients and identified 35 patients who had uncommon fatty clots, which the researchers named “leprosum clots.” The team studied what factors could signal the development of these clots and what molecules were existing in them.

Related Reports: 

Infusion Pump Market 

Halitosis Treatment Market 

 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

https://www.marketresearchfuture.com

 

Laser Therapy Market Size To Expand at a Notable CAGR Of 9.2% During 2017–2023

Laser Therapy Market Research Report, By Type (Diode Lasers, Solid State Lasers, Gas Lasers, Dye Lasers, and others), By Application (Dermatology and Aesthetics, Surgery, Dental, Urology, Ophthalmology, and others) — Global Forecast from 2017 to 2023

Market Research Future (MRFR) anticipates strong CAGR of 9.2% in the global laser therapy market over the forecast period of 2017–2023. The expansion of the global laser therapy is the result of various market dynamics, out of which, the surging prevalence of diseases such as cataract and arthritis bears profound weightage. Laser therapy is the standard line of treatment in cases of cataract. Laser-based ophthalmology is highly preferred over other methods of treatment. YAG LASER, excimer LASER, femtosecond LASER, and others are the most commonly used lasers in ophthalmology. The widespread prevalence of cataract, as well as arthritis, promote the growth of the global laser therapy market. Expanding base of old population complements this factor since the elderly populace is more prone to acquiring diseases such as arthritis and cataract which induces additional demand for laser therapy. Heightened demand for minimally-invasive and non-invasive procedures is a major drive behind the growth of the market. Consumers are highly inclined towards medical procedures which do not involve incisions and cuts. Additionally, laser therapy is extensively used in dermatology and cosmetology. Skyrocketing demand for aesthetics also encourages the growth of the global laser therapy market. Use of laser therapy in dentistry is also a key market influencer. On the contrary, the growth of the global laser therapy market might be impeded by high costs associated with laser therapy.

Segmentation

The global laser therapy market has been segmented based on type and application.

By type, the global laser therapy market has been segmented into diode lasers, solid state lasers, gas lasers, dye lasers, and others.

By application, the global laser therapy market has been segmented into surgery, dermatology and aesthetics, dental, and others. The surgery segment is further segmented into urology, ophthalmology, and others.

Regional Analysis

The Americas, Asia Pacific (APAC), Europe, and The Middle East & Africa (MEA) are the key markets for laser therapy.

The Americas is at the forefront of the global laser therapy market. A robust healthcare sector, high expenditure on healthcare, and widespread prevalence of chronic diseases in the region spur the growth of the global laser therapy market. In addition, the regions propensity to incorporate new and advanced technologies in the healthcare sector acts as a plus for the growth of the market. Other factors boosting the growth of the Americas market include growth in a number of aged populace and the presence of key players in the region.

Europe holds the second most significant share of the global laser therapy market. The region invests substantially in R&D activities which coupled with the availability of funds creates a conducive environment for the growth of the laser therapy market in Europe. A broad base of the patient population, well-developed healthcare sector, and high government support contribute to the growth of the market.

APAC is the fastest growing market for laser therapy. Expanding patient pool, development of the healthcare sector in the developing countries of China and India present growth opportunities to the APAC market. Also, increased affordability due to rising disposable income, government endeavors towards the modernization of the healthcare sector are other boosting factors.

The MEA market is likely to exhibit the least share of the global laser therapy market. Limited availability of healthcare facilities, lack of funds, and lack of awareness and dearth of skilled medical professionals constrain the growth of the market over the forecast period, especially in the Africa region. The Middle East accounts for the foremost share of the MEA market and is driven by high healthcare expenditure in the region.

Access Report Details @ https://www.marketresearchfuture.com/reports/laser-therapy-market-3812

Competitive Landscape

The key players in the global laser therapy market include Biolase Inc. (U.S.), Alma Lasers (Israel), Cutera (U.S.), IRIDEX Corp. (U.S.), Valeant (Canada), Coherent, Inc. (U.S.), and Angiodynamics, Inc. (U.S.).

Industry Updates

In December 2018, TRUMPF GmbH, a company involved in laser technology, announced the acquisition of Photonics GmbH from Philips. Through the acquisition, TRUMPF intends to expand its foothold in the growing markets in the photonics and digital products sectors.

Related news

Medical Tourism Market
Immunoassay Analyzers Market Share

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact

https://www.marketresearchfuture.com

Optical Coherence Tomography Market | Worldwide Overview by Size, Share, Trends, Segments, Leading Players, Demand and Supply with Regional Forecast - 2023

Global Optical Coherence Tomography (OCT) Market Size, Trends and Share Analysis By Technology (Sd-Oct, Swept-Source Oct), Application (Cardiology, Ophthalmology, Dermatology, Others), Type Of Devices (Handheld, Tabletop, Catheter-Based Oct Devices), Key Players and Region, Forecast to 2023

 

Augmenting demand for advanced devices that can provide a faster diagnosis with higher accuracy and advancements in optical coherence tomography are some of the key driving forces pushing the Optical Coherence Tomography Market growth.

Additionally, factors such as the ongoing product development & commercialization led by the favourable reimbursement policies and rising number of approvals from regulatory bodies are boosting the optical coherence tomography market growth. Moreover, increasing the adoption of OCT as one of the most critical imaging techniques in various medical applications is contributing to the growth of the optical coherence tomography market.

 

On the flip side, the high cost and the scepticism of physicians towards the advancement & efficacies of OCT devices inhibit the optical coherence tomography market growth. Also, the need for physician's training is a significant factor expected to obstruct the market growth during the assessment period. Nevertheless, efforts & investments transpired into the R&D activities by the key market players would support the growth of the market, bringing about cost-effective solutions.

Optical Coherence Tomography Market Segmentation:


Application
Type of Devices

 

Based on Technology, the optical coherence tomography market is segmented into

Swept-Source OCT
Spectral-Domain OCT (SD-OCT)
others

 

Based on Application Optical Coherence Tomography (OCT) market is segmented into

Ophthalmology
Dermatology
Cardiology
others

 

Based on Type of Devices Optical Coherence Tomography (OCT) market is segmented into

Table-top
Handheld
Catheter-based OCT Devices
others

 

Optical Coherence Tomography Market Geographical Analysis:

 

North America is projected to retain its leading position in the global optical coherence tomography market throughout the forecast period. The presence of a large diabetic patient population substantiates the regional market growth, augmenting the demand for diabetic retinopathy. Besides, neurovascular and other eye-related diseases are supporting the growth of the regional market.

 

Additional factors such as the rising demand for minimally invasive and technologically advanced treatments, alongside the tremendous government support and high healthcare expenditures, foster the regional market growth. Furthermore, the presence of the growing number of diabetic patients and leading players propels the regional market.

The European optical coherence tomography market stands second on a global level. Factors boosting the regional market growth include the presence of well-established healthcare sectors and the growing number of advanced treatment facilities in the region. Moreover, the increasing demand for better healthcare infrastructure, led by the rising prevalence of diabetes and increasing per-capita healthcare expenses, drive enormous market demand.

 

The optical coherence tomography market in the Asia Pacific region is emerging as a lucrative market, globally, witnessing increased funding support from the private and public sectors. Moreover, increasing R&D activities and the rising number of diabetic retinopathy & other eye diseases are some of the key factors fostering regional market growth. Furthermore, increasing access to new treatment methods is expected to support the APAC OCT market, increasingly meeting the growing demand for treatments of prevailing optical diseases.

 

Optical Coherence Tomography (OCT) Market Competitive Analysis:

 

Fiercely competitive, the optical coherence tomography (OCT) market appears to be fragmented due to the presence of several well-established players. To gain a substantially larger share in the market, players incorporate strategic initiatives such as mergers & acquisitions, collaborations, expansion, and new therapeutics & technology launch. High potential growth opportunities demonstrated by the market attract several new entrants, which further intensifies the market competition. Players also substantially invest in R&D to develop advanced technologies and devices with unique features.

 

Optical Coherence Tomography Market Major Players:

 

Players leading the global optical coherence tomography (OCT) market are Abbott Laboratories, Alcon, Carl Zeiss AG, Terumo Corporation, Koninklijke Philips N.V, B. Braun Melsungen AG, Boston Scientific Corporation, Topcon Corporation, NIDEK Co., Ltd, Novacam Technologies Inc., OPTOPOL Technology S.A, Heidelberg Engineering GmbH, Imalux Corporation, Michelson Diagnostics, Agfa Healthcare, and Thorlabs Inc. among others.

 

Industry/Innovation/Related News:

 

Canon U.S.A., Inc., a leading provider of digital imaging solutions, announced that its new intuitive, user-friendly Xephilio OCT-A1 Optical Coherence Tomography device has received FDA 510(k) clearance for sale in the US. The Xephilio OCT-A1 features automated acquisition functionality, which allows obtaining high-quality, reproducible scans and images.

 

Canon's optical coherence tomography device is indicated for the in-vivo imaging and measurement of the retina, retinal nerve fiber layer, and optic disc. Besides, the Xephilio OCT-A1 System can identify the disease state and monitor disease conditions before and after treatments in private ophthalmology practices, retinal clinics, teaching hospitals, and institutions.

 

The versatile OCT device can be used in a variety of settings, including telehealth and telemedicine primary care providers. For optometry practices and optometric schools, this System can aid in recognizing diseases & conditions in primary care.

 

Browse Full Research Report

At https://www.marketresearchfuture.com/reports/optical-coherence-tomography-market-1328

 

Related News

 

DNA Sequencing Market

Vein illuminator Market

 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Zika Virus Testing Market Product Scope Global Trend and Industry Share Analysis

Zika Virus Testing Market is anticipated to be driven by increasing Zika incidences around the globe. This virus was first detected in Rhesus monkeys in Uganda in 1947. Then, in 1952, humans were detected with the virus.

The “Zika Virus Testing Market” In-Depth competition analysis of the major companies in the report, sector of the report includes the market depictions, requirements, and product portrayals, manufacture, competence, contact figures, cost, and revenue.

The Zika Virus Testing Market Free Growth Sample will provide valuable insight with an emphasis on the global market including some of the major players such As, ARUP Laboratories, Hologic, Luminex Corporation, Roche Molecular Systems, etc.

Various application sub-segments of the industry comprise hospitals, ambulatory centers, pathology laboratories, diagnostic centers, etc. The different screening tests include nucleic acid amplification and Zika virus antibody. Based on geographies, the market is classified on the basis of Europe, Asia Pacific, Americas, and the Middle East and Africa.

The steady transfer of Zika in Americas has led to the demand for effective screening services till the end of the forecast period. The continuous demand for the better identification & management of this illness should propel industry sales.

Zika Virus Testing Market Segment by Regions, regional analysis covers:

  • North America(United States, Canada and Mexico)
  • Europe(Germany, France, UK, Russia and Italy)
  • Asia-Pacific(China, Japan, Korea, India and Southeast Asia)
  • South America(Brazil, Argentina, Colombia etc.)
  • Middle East and Africa(Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Reasons to Purchase this Report

  • Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
  • Provision of market value (USD Billion) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • The competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled

Access Complete Detailed TOC Research Report at https://www.marketresearchfuture.com/reports/zika-virus-testing-market-5662

For Market Zika Virus Testing Market analysis, the report covers upstream raw materials, equipment, downstream client survey, Marketing channels, Market development trend and proposals, which more specifically include valuable information By key applications and consumption, key regions and consumption, key Global distributors , major raw materials suppliers and contact information, major manufacturing equipment suppliers and contact information, major suppliers and contact Information, key consumers and contact information, and supply.

About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

mHealth Applications Market Growth 2020, Innovation, Increasing Digitalization, Dynamics, Specification, Business Opportunities by Forecast 2022

mHealth Market Information, By Therapeutics(respiratory, mental and neurological disorders, fitness & lifestyle) By Application(monitoring, diagnosis & treatment, wellness & prevention) – Forecast to 2022

Leading Market Players

Allscripts, Agamatrix, Inc., Medtronic MiniMed, Inc., Honeywell International Inc., Vivify Health, iHealth Labs Inc., and Apple Inc. are some of the key players operational in the global mHealth applications market.

Overview:

The global market for mHealth applications is depending on a thrust that can be provided by the IT sector in the coming years. The growth, as discussed by Market Research Future (MRFR), can reach a valuation of USD 100.2 Bn by 2023. MRFR considers 2016 to 2023 as the forecast period where the growth for the market would be substantial. Growing demand for mHealth is winning traction from sectors like transforming face of the traditional medical practices, creation of the path for better healthcare in the future, and others. Growing inclusion of better internet facilities, Bluetooth, and Wi-fi can inspire better growth for the market.

Segmentation Analysis

The global mHealth applications market report is segmented by type.

By drug type, it is segmented into wellness & prevention, education & awareness, diagnosis & treatment, monitoring applications, and healthcare management. Monitoring applications held close to 53.8% market share in 2016. This can be attributed to alarming levels of diabetes, obesity, and cardiovascular diseases which need to be controlled. In addition, demand for disease management in rural areas can drive the segment growth in the coming years.

Regional Analysis

North America, Asia Pacific (APAC), Europe, and the Rest-of-the-World (RoW) are the regions being considered for the basis of the report.

Europe has the lead in the global mHealth applications market owing to efforts taken by various healthcare developers in extending the research of chronic diseases. Prevalence of rare diseases as well as the capacity of wearables to record information assisted pharma companies in improving their outcomes at a rapid pace.

The APAC region is the second-largest in terms of revenue in the market. This can be attributed to consolidation among hospital chains as well as efforts to lower patient burden on hospital staff. In addition, policies for digitization of hospital data and approval of mHealth applications by doctors and physicians can bolster the market growth. The region can exhibit 33.7% CAGR during the forecast period.

TABLE OF CONTENT

3 MARKET OVERVIEW

3.1 INTRODUCTION

3.2 MARKET DYNAMICS

3.2.1 MARKET DRIVERS

3.2.1.1 Patients Involvement In Personal Healthcare

3.2.1.2 Proliferation Of Smartphones And Wearable Devices Into Healthcare

3.2.1.3 Integration Of Wireless Technologies With Portable Healthcare Devices

3.2.1.4 Introduction Of Connected Healthcare Solutions In The MHealth Market

3.2.1.5 Benefits Of Cost Effectiveness And Patients’ Convenience

3.2.1.6 Increase In Lifestyle Disease

3.2.2 MARKET CHALLENGES

3.2.2.1 Low Rate Of Literacy And Language Barriers In Low- And Middle-Income Countries (LMICs)

3.2.2.2 Invasion Of Privacy

3.2.2.2.1 Security Breach Cases

3.2.2.2.2 Potential Risk Of Hardware Or Software Failure

3.2.2.2.3 Stringent Regulations And Standards

3.2.2.2.4 Lack Of Awareness About The Possible Applications Of MHealth

3.2.3 MARKET OPPORTUNITIES

3.2.3.1 Partnership: An Entry Mode

3.2.3.2 Introduction Of MHealth In Developing Economies

CONTINUED..

COLLECT DETAILED REPORT INFORMATION @ https://www.marketresearchfuture.com/reports/mobile-health-market-1816

June 2019: University of Washington’s researchers are coming up with a mHealth app which will integrate with various digital platforms such as Google Home or Amazon Alexa and monitor the breathing patterns of a user during sleep for the evidence of a cardiac arrest. This digital health tool will use artificial intelligence technology.

RELATED TRENDING REPORTS

Prostate cancer Market

 Infusion Pump Market

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Artificial Neural Network Market Size 2020, Industry Growth, Size, Company Profiles, Regional Study, Business Trends, Landscape and Demand with Forecast 2023

Global Artificial Neural Network Market Research Report: By Type (Feedback Artificial Neural Network, Feedforward Artificial Neural Network, Other), by Component (Software, Services, Other), by Application (Drug Development, Others) – Forecast Till 2023

Leading Market Players

Key players profiled in the artificial neural network market include Oracle Corporation, IBM Corporation, Microsoft Corporation, Intel Corporation, Qualcomm Technologies, Inc., Neuralware, Google Inc., Alyuda Research, LLC., NeuroDimension, Inc., SAP SE, Ward Systems Group, Inc., Afiniti, SwiftKey, Neural Technologies Limited, and Starmind International AG.

Get free sample @ https://www.marketresearchfuture.com/sample_request/6287

Market Overview

The global artificial neural network market is expected to exhibit a stellar growth rate from 2018 to 2023 (forecast period). Emergence of ANN in healthcare and finance sectors are predicted to drive the market growth. Increasing prevalence of chronic diseases, growing number of admissions in hospitals, and inflated healthcare expenditure of nations are other drivers supporting the adoption of ANN in healthcare. Development of software to support the large patient volume can drive the market growth. For instance, the MAQ software by Microsoft Corporation contains an ANN to predict future trends.

Segmentation

The artificial neural network market is segmented by type, component, and application.

By type, it is segmented into feedback artificial neural network, feedforward artificial neural network, and others. The feedforward artificial neural network segment is expected to reign supreme over the forecast period due to immense demand for advanced analytical systems.

By component, it is segmented into software, services, and platform.

By application, it is segmented into drug development, image analysis and interpretation, bioelectric signal analysis and interpretation, clinical diagnosis and prognostics, and others. The image analysis application is projected to possess future potential due to the use of deep learning algorithms for identifying faces in massive crowds. This is highly useful for law enforcement agencies in thwarting potential attacks.

Regional Analysis

Regionally, the artificial neural network market covers the Americas, Asia Pacific (APAC), Europe, and the Middle East & Africa.

The Americas is anticipated to be the dominant region in the global market due to large number of enterprises for development of neural network technologies and well-developed healthcare sector. The large healthcare expenditure for the region is likely to bode well for the market growth. Emergence of self-driving or autonomous driving has gained the interest of various manufacturers in the technology. Artificial neurons can be used in analyzing driver behavior on the roads. This has become useful for Tesla, one of the biggest advocates of self-driving cars, in developing its Self Driving Computer.

Europe is assumed to be in the second position in the global market due to inflated healthcare expenditure and adoption of AI among healthcare providers. The ballooned defense expenditure of nations is likely to fuel the adoption of ANN and deep learning to further the development of autonomous systems to strengthen existing defenses. On the other hand, the APAC region is presumed to exhibit the fastest growth rate during the forecast period due to need to control healthcare costs and rising economic growth of countries. Digitization of patient records is expected to influence the market growth.

Table Of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Continued…

Collect detailed report @ https://www.marketresearchfuture.com/reports/artificial-neural-network-market-6287

In August 2019, Google researchers launched the new Weight Agnostic Neural Networks that would perform without assessing the weight first. This would help in devising programs that would require no training.

Related Trending Healthcare Reports

mHealth Applications Market

 

Mucormycosis Market

 

About Market Research Future:

MRFR team has supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country-level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Epigenetics Market Analysis 2020 | Share Analysis, Market Value, Size Estimation, Future Trends and Global Industry Insight

Epigenetics is the analysis and study of heritable changes in gene function not involving changes in the DNA sequence such as changes in a chromosome, phenotypic affecting gene activity, and expression.

The global epigenetics market is valued at USD 800 million in 2016 and is expected to expand at a 12.9 % CAGR during the study period of 2016 to 2023.

Market Dynamics:

Oncology Segment Is Expected To Be The Largest Driver Of Market Growth

The growing incidence of cancer is the prime drivers of the market. According to W.H.O. cancer was responsible for 8.8 million deaths in 2015, indenting nearly 1 in 6 patient’s deaths. Common carcinomas are lung cancer, liver cancer, colorectal cancer, stomach cancer, and breast cancer, recording 1.69 million, 788,000, 774 thousand, 754 thousand, and 571 thousand deaths respectively in the year 2015. According to the estimates of the Centers for Disease Control and Prevention, almost 1.5 million people are diagnosed with cancer per year in the U.S. alone, resulting in more than five lakh deaths.

Technology Development Is Expected To Drive A Faster Market Adoption

The development of highly sensitive and selective tests, instrumentation and a concurrent rise in computational power is driving a broad adoption. The advancements such as the development of DNA and RNA modifying enzymes such as acetylases, methyltransferases, reverse transcriptase, ligases, and other protein-modifying enzymes has generated tremendous enthusiasm and concurrent faster market adoption.

The growing government support for biotechnology and growing partnership between academia and industry is another driver of growth. Attractive and critical advantages of technology exemplified by high-throughput molecular analysis of tissues, such as quick, cost-effective, efficient for less labor intensive and requires a lesser number of steps are the operational and economic driving factors of the market. Other technological developments include automation, advances in PCR technology, strategic and cross-functional nature of the molecular diagnostic technology and others.
High Cost Of Installation And Maintenance And Nascent Stage Of Technology May Hamper The Market Growth

The prime market constraints include prohibitive costs of molecular diagnostics, the high cost of manufacturing, consolidated nature of the market has put a premium on the price of the epigenetics products, nascent stage of technology and high power of firms relative to buyers.

Segments:

To generate a bird’s view of the global epigenetics market, the report is segmented based on instruments, consumables, applications, technology, end users, and regions.

Based on instruments, the market comprises of NGS, spectrometer, PCR, software solutions and others.

Based on consumables, the market comprises of kit, enzymes, reagent, and others.
Based on application, the market comprises of oncology, developmental biology, drug discovery, cardiology, immunology, and others
.
Based on technology, the market comprises of methylation, histone modification, and others.

Based on end users the market is segmented into academia and research, pharmaceutical and biotechnology industry and others.

Based on the regions, the market is segmented as North America, Europe, Asia Pacific Middle East and Africa and rest of the world.

Regional analysis:

North America led by the U.S. accounts for the most significant market share of the market, owing to faster technology uptake, the large biotech sector of the U.S., the presence of large advanced players, growing prevalence of cancer.

Europe led by Germany, U.K., and France accounts for the second-largest and second fastest market during the forecasted period. Asia led by Japan and supported by China, South Korea, and India is anticipated to be the fastest growing market.

The Middle East and Africa market will expand at a slower rate on account of the weak industry landscape and low demand due to weak economic conditions.

Key Vendors:

Some of the dominant vendors operating in the report are Bio-Rad (US), Illumina (US), QIAGEN (Netherlands), Thermo Fisher (US), Active Motif (US), Diagenode (Belgium), Agilent (US), Merck Millipore (US), Abcam (UK), New England Biolabs (US), PerkinElmer (US), Zymo Research (US), and others.

Access Report @
 https://www.marketresearchfuture.com/upcoming-reports/epigenetics-market-6161

Intended Audience

  • Pharmaceutical companies
  • Biotechnological institutes
  • Research and Development (R&D) Companies
  • Medical Research Laboratories
  • Market Research and Consulting Service Providers

Related News
Sex Cord Gonadal Stromal Tumor Market

Bariatric Surgery Devices Market

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Ophthalmic Equipment Market Devices, By Top Key Players, Global Industry Size, Growth Opportunity, Latest Trends and Advanced Technologies To 2023

MRFR’s Outlook towards the Worldwide Ophthalmic Equipment Market Remains Positive with a 5.4 % CAGR forecast for the Next Five Years.  And Provide Overview of Key Players and their Strategic Profiling in the Market, Comprehensively Analyzing their Core Competencies, and Drawing a Competitive Landscape for the Market.

 

Ophthalmic Equipment Market – Key Players

 

Some of the key players in this market are Alcon (U.S.), Bausch & Lomb (U.S.), Carl Zeiss Meditec (Germany), Johnson & Johnson (U.S.), Essilor International S.A. (France), Haag-Streit (Switzerland), Nidek (Korea), Staar Surgical (U.S.), Topcon Corporation (Japan), Ziemer Ophthalmic Systems (Switzerland), Hoya Corporation (Japan), Ridex Corporation (U.S.), and others.

 

 Ophthalmic Equipment Market – Highlights

 

The market in Asia Pacific is expected to grow rapidly in the coming years. Based on a detailed study and analysis, it is found that this region has a good growth potential due to the increasing unhealthy eating habits and unhygienic conditions. Major factors driving the market are increasing geriatric population and increasing healthcare expenditure. On the other hand, low awareness in developing and underdeveloped regions regarding ophthalmic diseases may hamper the market growth during the forecast period.

 

Ophthalmic Equipment Market – Segmentation

 

The global ophthalmic equipment market is segmented on the basis of product, application, and end-user.

On the basis of product, the market is segmented into vision care devices, ophthalmology surgical devices, diagnostic and monitoring devices, and others. Vision care devices a segmented into spectacles and contact lens. Contact lenses are further segmented into soft contact lenses, Rigid Gas Permeable lenses (RGP), and hybrid contact lenses. Ophthalmology surgical devices are segmented into cataract surgical devices, vitreoretinal surgical devices, refractive surgical devices, glaucoma surgical devices, ophthalmic microscopes, ophthalmic accessories, and others. Cataract surgical devices are further segmented into Intraocular Lenses (IOLS), Ophthalmic Viscoelastic Devices (OVDS), phacoemulsification devices, cataract surgical lasers, and others. 

 

The vitreoretinal surgical devices segment is further segmented into vitreoretinal packs, vitrectomy machines, photocoagulation lasers, illumination devices, vitrectomy probes, and others. The refractive surgical devices segment is further segmented into femtosecond lasers, excimer lasers, and others. Glaucoma surgical devices are further segmented into Glaucoma Drainage Devices (GDDS), and micro-invasive glaucoma surgical devices. Ophthalmic accessories are further segmented into surgical instruments and kits, ophthalmic forceps, ophthalmic spatulas, ophthalmic tips and handles, ophthalmic scissors, macular lenses, ophthalmic cannulas, and others. 

 

Diagnostic and monitoring devices are segmented into optical coherence tomography scanners, fundus cameras, perimeters/visual field analyzers, autorefractors and keratometers, ophthalmic ultrasound imaging systems, tonometers, slit lamps, phoropters, wavefront aberrometers, optical biometry systems, ophthalmoscopes, lensmeters, corneal topography systems, chart projectors, specular microscopes, retinoscopes, and others. Ophthalmic ultrasound imaging systems are further segmented into ophthalmic A-scan ultrasound, ophthalmic b-scan ultrasound, ophthalmic ultrasound biomicroscopes, and ophthalmic pachymeters.

On the basis of application, the market is segmented into glaucoma, amblyopia, cataract, retinal detachment, and others.

 

On the basis of end-user, the market is segmented into hospitals, ophthalmology clinics, diagnostic centers, research centers, and others.

 

Ophthalmic Equipment Market – Regional Analysis 

 

The Americas dominates the global ophthalmic equipment market owing to the increasing prevalence of ophthalmic diseases and presence of a well-developed healthcare sector within the region. Moreover, the increasing healthcare expenditure and presence of key players within the regional boundaries provide a favorable background for the market growth.

 

Europe is the second largest in the global ophthalmic equipment market. Factors such as the increasing availability of funds for research and a huge patient population followed by a well-developed healthcare sector drive the market within the region.

 

Asia Pacific is estimated to be the fastest growing market for ophthalmic equipment. This can be attributed to the presence of developing economies such as India and China and a huge patient population suffering from ophthalmic diseases. Moreover, the increasing healthcare expenditure and a rapidly developing healthcare sector boost the market growth within the region.

 

On the other hand, the Middle East and Africa has the least share in the global ophthalmic equipment market due to the low per capita healthcare expenditure and stringent government policies, especially within the African region. It is estimated that the Middle East holds a majority of the market within the Middle Eastern and African region.

 

Browse Complete 100 Pages Premium Research Report Enabled with 82 Respective Tables and Figures at https://www.marketresearchfuture.com/reports/ophthalmic-equipment-market-5973

 

Related Healthcare News

 

Telemedicine Market

Infection Control Market

 

About Market Research Future:

 

 MRFR team has supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country-level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions

 

 Contact:

www.marketresearchfuture.com

Sex Cord Gonadal Stromal Tumor Market Analysis Devices, By Top Key Players, Global Industry Size, Growth Opportunity, Latest Trends and Advanced Technologies To 2023

Market Highlights

The sex cord-gonadal stromal tumor is a rare type of cancer derived from the stromal component of the ovary and testis. This tumor comprises granulosa, thecal cells, and fibrocytes. Sex cord-gonadal stromal tumors are mostly of seven types, namely, granulosa cell tumor, Sertoli cell tumor, thecoma, Leydig cell tumor, gynandroblastoma, Sex Cord Tumor with Annular Tubules (SCTAT), and Sertoli Leydig cell tumor. In humans, this type of tumor accounts for 8% of the ovarian cancers and around 5% of testicular cancers.

 

It is noted that the increasing cases of ovarian and testicular cancer, technological advancements, and increasing healthcare expenditure are the key factors driving the sex cord gonadal stromal tumor market.

 

 Various other factors such as the growing awareness about the cord-gonadal stromal tumor, unmet medical needs, enhancing regulatory framework, increasing government assistance, and rising funding and reimbursement are continuously contributing to the growth of the global sex cord-gonadal stromal tumor market.

Owing to the increasing cases of ovarian and testicular cancer, technological advancements, increasing healthcare expenditure, growing awareness about sex cord-gonadal stromal tumor, unmet medical needs, enhancing regulatory framework, increasing government assistance, and rising funding and reimbursement, the sex cord-gonadal stromal tumor market has evolved significantly.

 

However, huge capital investments with low-profit margins, strict FDA regulations, and poor healthcare system in low and middle-income countries are likely to hamper the growth of the sex cord-gonadal stromal tumor market over the forecast period.

 

It is estimated that the sex cord-gonadal stromal tumor market is expected to grow at a CAGR of 6.5% during the forecast period of 2017-2023.

 

Key Players

 

Some of the key players in the global sex cord-gonadal stromal tumor market are Abbott, Abcam plc, Affymetrix, Inc., Agilent Technologies, Inc., Beckman, Dickinson and Company (BD), Bio SB Inc., BioCurex, BioModa, Inc., Bio-Rad Laboratories, Inc., Boston Scientific Corporation, Cell Signaling Technology, Inc., Clarient, Inc., CooperSurgical Inc., Correlogic Systems, Inc., Danaher Corporation, Epigenomics AG, F. Hoffmann-La Roche AG, Gen-Probe, Inc., Hologic, Inc., Johnson & Johnson Services, Inc., Karl Storz GmbH & Co. Kg, LiNA Medical USA, Merck Millipore, PerkinElmer, Inc., Qiagen, Radient Pharmaceuticals, Thermo Fisher Scientific Inc., Veridex LLC, and others.

 

Regional Analysis

 

The Americas dominates the sex cord-gonadal stromal tumor market owing to the increasing prevalence of ovarian cancer in this region and high healthcare expenditure. According to the American Cancer Society, around 22,240 women are likely to be diagnosed with ovarian cancer, and 14,070 women are likely to die from ovarian cancer, in 2018.

 

Europe holds the second position in the sex cord-gonadal stromal tumor market. The financial support provided by the government towards R&D and technological advancements are expected to drive the European sex cord-gonadal stromal tumor market. The increasing healthcare expenditure is also boosting the European sex cord-gonadal stromal tumor market.

 

According to the data suggested by Eurostat, it is observed that among the EU Member States, the highest value of healthcare expenditure was recorded in Germany in 2014, i.e., EUR 321 billion which is further followed by France with EUR 237 billion and United Kingdom with EUR 223 billion. In 2016, the R&D expenditure in the pharmaceutical industry was EUR 35000 million, suggested by the European Federation of Pharmaceutical Industries and Association.

 

Asia Pacific is the fastest growing sex cord-gonadal stromal tumor market owing to a huge patient pool and development in the pharmaceutical sector. Healthcare expenditure is found to be boosting in various regions of Asia Pacific. As per the data suggested by the Australian Institute of Health and Welfare during the year 2015-2016, the total health expenditure was nearly USD 170.4 billion, i.e., 3.6% higher than the expenditure of 2014-2015.

 

The Middle East and Africa holds the lowest share of the global market due to slow development, lack of technical knowledge, and poor medical facilities.

 

Segmentation

 

The global sex cord-gonadal stromal tumor market is segmented on the basis of type, diagnosis, treatment, and end-user.

 

On the basis of tumor type, the sex cord-gonadal stromal tumor market is classified as granulosa cell tumor, Sertoli cell tumor, thecoma, Leydig cell tumor, Sertoli Leydig cell tumor, gynandroblastoma, and Sex Cord Tumor with Annular Tubules (SCTAT). The granulosa cell tumor is further classified as functioning tumors and non-functioning tumors.

 

On the basis of diagnosis, the sex cord-gonadal stromal tumor market is classified as microscopy immunohistochemistry, tumor marker, ultrasound, Magnetic Resonance Imaging (MRI), and others. The tumor marker segment is further classified as inhibin-alpha, calretinin, Melan-A, and others.

 

On the basis of treatment, the sex cord-gonadal stromal tumor market is classified as chemotherapy, radiotherapy, surgery, and others. The surgery segment is further classified as salpingo-oophorectomy, abdominal hysterectomy, Retroperitoneal Lymph Node Dissection (RPLND), and radical inguinal orchiectomy. The sub-segment of salpingo-oophorectomy includes unilateral salpingo-oophorectomy and bilateral salpingo-oophorectomy.

 

On the basis of end-user, the sex cord-gonadal stromal tumor market is segmented into hospitals and clinics, cancer research centers, research and academic institutes, and others.

 

Get full report @https://www.marketresearchfuture.com/reports/sex-cord-gonadal-stromal-tumor-market-5912

 

Intended Audience

 

Medical Device Companies
Research and Development (R&D) Companies
Diagnostic Laboratories
Government Research Institutes
Academic Institutes and Universities

 

Browse other healthcare related report

 

Sex Cord Gonadal Stromal Tumor Market

Endometrial Cancer Market 

 

About Market Research Future:

 

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

 

Contact:

https://www.marketresearchfuture.com

Influenza Vaccination Market Synopsis by Leading Players | Industry to Hold Success by Crossing 8.2% CAGR by Increase in Demand Supply

Market Research Future added a new Report in their huge database named as “Global Influenza Vaccination Market”. Report include top international players success milestones, industry recent trends, demand-supply and forecast up to 2023 — Experts predict that Influenza Vaccination Market will grow at an approximate CAGR of 8.2% during the forecast period.

Influenza (flu) is a contagious respiratory disease caused by influenza viruses that infect the respiratory tract (nose, throat, and lungs) in humans. The symptoms and complications of flu are more severe than common cold. The symptoms associated with influenza may include fever, headache, malaise, cough, sore throat, nasal congestion, and body aches. Influenza vaccine can prevent illness and death caused by the influenza virus. Influenza vaccine can be administrated to both young and old patients. According to the Centers for Disease Control and Prevention in 2017, 67.2% of all the geriatric population within the U.S. suffered from influenza in 2016.

Moreover, it was estimated that the disease caused 4,605 deaths in 2014. Such trends in the prevalence of influenza are the major driver for the market growth during the forecast period. Moreover, the immune-compromised growing geriatric population, increasing per capita healthcare expenditure and rising awareness of the disease will fuel the market growth. According to the National Institutes of Health, the people who age 80 or more are expected to grow from 126.5 million in 2015 to 446.6 million by 2050. However, stringent regulatory framework along with the low accessibility of the product in the developing countries may restrain the market growth.

Key Players for Global Influenza Vaccination Market

Some of the key players for the global influenza vaccination market are Abbott (U.S.), AstraZeneca (Europe), BioCryst Pharmaceuticals, Inc. (U.S.), Novartis AG (Europe), DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific), GlaxoSmithKline plc. (Europe). Hualan Biological Engineering Inc (Asia Pacific), Mitsubishi Tanabe Pharma Corporation (Asia Pacific), F. Hoffmann-La Roche Ltd (Europe), Sanofi (Europe), and others.

Segments for Global Influenza Vaccination Market

The global influenza vaccination market is segmented on the basis of type of influenza, manufacturing technology, vaccines, and others.

On the basis of the type of influenza, the market is segmented into seasonal, pandemic, zoonotic, and others., on the basis of the manufacturing technology, the market is segmented into egg based, cell culture based, recombination based technology, and others, on the basis of the vaccines, the market is segmented into fluzone, flumist, fluvax, fluvirin, and others and On the basis of the end users, the market is segmented into hospital & clinics, research organization, academic institutes, and others.

Regional Analysis for Global Influenza Vaccination Market

The Americas dominate the global influenza vaccination market owing to the increasing prevalence of influenza and the high per capita healthcare expenditure. Moreover, the presence of the developed economies like the U.S. and Canada within the region boosts the growth of the market. Additionally, growing geriatric population within the regional boundaries of the Americas fuels the market growth. According to the National Institutes of Health, the America’s geriatric population is expected to reach 88 million by 2050.

Europe is the second largest market for influenza vaccination, which is followed by Asia Pacific. Availability of funds for research, a well-developed healthcare infrastructure, and a huge patient population drives the market growth within the region. Moreover, rising healthcare expenditure along with the government support for research & development boosts the market in Europe. Additionally, the presence of the global players like F. Hoffmann-La Roche Ltd and Novartis AG within the region fuels the regional market.

Asia Pacific is the fastest growing region for the market due to the presence of developing economies like India and China. Moreover, favorable government policies and growing geriatric population will boost the market growth within the region.

The Middle East & Africa has the least share in the global influenza vaccination market due to the presence of poor economies, especially in the African region. Majority of the market of the Middle & Africa region is held by the Middle East owing to the presence of developed economies like Saudi Arabia, Kuwait, and Qatar within the region.

Browse Complete Report @ https://www.marketresearchfuture.com/reports/influenza-vaccination-market-1621

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

 
 
 
 
 
 

myomectomy market is expected to grow at a CAGR of 6.9% during the forecast period.

Myomectomy Industry Research Report published by Market Research Future (MRFR) Covers Historical Market Trends, Current Market Dynamics, Market Valuation by Segmentation as Well as Region, Country-level Analysis for Every Segment, Key Player’s Market Share Analysis, Competitive Landscape and Supply Chain Analysis.

Major Players in Myomectomy Industry:

Some of the key players in the global market are Halt Medical, Inc. (U.K), Boston Scientific Corporation (U.S.), CooperSurgical Inc. (U.S.), C. R. Bard, Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), General Electric Company (U.S.), KARL STORZ SE & Co. KG (Germany), Richard Wolf Medical Instruments (U.S.), Siemens (U.S.), AbbVie Inc. (U.S.), Bayer (Germany), Eli Lilly and Company (U.S.), Johnson & Johnson Services Inc. (U.S.) and others

The global myomectomy market is expected to grow at a CAGR of 6.9% during the forecast period.

Myomectomy Industry Overview

Myomectomy is surgical procedure for the removal of uterine fibroids. Uterine fibroid, also known as leiomyoma or myomas, is a non-cancerous growth that develops inside or on the wall of a woman’s uterus. Heavy bleeding between or during the menstrual cycle, pain in pelvis or lower back, increased menstrual cramps are major symptoms for uterine fibroids.

Prevalence of uterine disorders abnormal uterine bleeding (AUB), amenorrhea, dysmenorrhea (painful menstrual periods, and premenstrual syndrome (PMS) is on the rise across the globe, especially in the developing countries. In addition, increasing research and development activities, and technological advancements to identify the causes and risk factors for such disorders is fuelling the global myomectomy market growth. There is also an increasing demand for technologically advanced devices for the diagnosis of uterine fibroids. Increasing awareness about the reproductive health, and diseases among women across the globe also determine the growth of the market. The key players are now focusing on the geographical expansion in the developing regions such as Asia Pacific.

Uterine fibroids affects nearly 40% of women in the age group of 30 and 55, including 20 million women in North America and 24 million women in Europe with over 7 million patients worldwide presently undergo various symptom management treatments.

Segmentation

  • On the basis of type, market is segmented into abdominal, hysteroscopic, laparoscopic, and robotic.
  • On the basis of product, the market is segmented into laparoscopic power morcellators, harmonic scalpel, laparoscopic sealer, and others.
  • On the basis of end user, the market is segmented into hospitals & clinics, surgical centers, medical device companies, and others.

 

Regional Analysis

In the Americas, the market for myomectomy is found to be growing from the last few years and expected to exhibit tremendous growth during the forecast period. Rising prevalence of uterine disorders, and other reproductive health problems, emphasis on healthy lifestyle, and availability of specialized healthcare services conditions are important drivers for the growth of the market. Also, increasing demand for technologically advanced diagnostic devices and presence of major market players also influence the growth of the market.

According to the U.S. Department of Health and Human Services Office on Women's Health, about 30% of all women will get them by age 35, and around 20-80%of women will do so by age 50. For some reason, African American women are more likely to experience fibroids, and to do so at a younger age.

In Europe, the rising awareness about surgical procedures available for the treatment of uterine fibroids, and extensive research and development activities on the medical devices drive the market growth. The overall growth of healthcare diagnostic and imaging services also determine the growth of the market. Germany, U.K and France are the major contributors to the growth of the market owing to rising emphasis on the diagnosis and treatment of uterine disorders,and strengthening healthcare system.

In Asia Pacific, rising awareness about the reproductive health, and its diagnosis, and treatment of uterine disorders are major drivers for the growth of the market. Additionally, increasing healthcare expenditure, and overall demand for medical devices also accelerate the market. India & China are the largest contributors to the growth of the market owing rising emphasis on treatment of chronic diseases and increasing government support.

In the Middle East & Africa, the market is expected to show steady growth owing to low technology penetration, and rising prevalence of chronic diseases. The Middle East is the largest market for myomectomy owing to availability of specialty services in regions such as the United Arab Emirates, and Saudi Arabia.

BROWSE FULL REPORT @ https://www.marketresearchfuture.com/reports/myomectomy-market-5149 .

Browse more Healthcare Related Reports

Medical Tourism Market

 

Mucormycosis Market

 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

:

 

Home Healthcare Market Analysis 2020 Global Trends, Size, Opportunities, Sales Revenue, Emerging Technologies and Growth Analysis By 2023

Home Healthcare Market Size Research Report — Forecast to 2023 includes a vast number of healthcare services that are provided to the patient in their home in case of illness or injuries. Home healthcare is typically less expensive, convenient, and just as effective as a hospital or a nursing facility.

Technological advancements in healthcare and diagnosis equipment and changing government initiatives encouraging the adoption of home healthcare are most likely to boost the market demand. The patient demand has prompted prominent market players to take notice. However, concerns related to patient safety can impede the growth of the market.

Home Healthcare Market Segmentation

By product, the Home Healthcare Market is segmented into testing, screening and monitoring products and therapeutic products. The testing, screening, and monitoring segment is expected to continue to lead the global market owing to the increasing demand for home healthcare solutions. This segment is anticipated to register a CAGR of 8.5% during the forecast period.

The testing, screening, and monitoring products are further segmented into blood glucose monitors, blood pressure monitors, sleep apnea monitors, pulse oximeters and heart rate monitors, cholesterol monitoring devices, Holter and event monitors, and others. Therapeutic products are segmented into respiratory therapy equipment, insulin delivery devices, IV equipment, wound care products, dialysis equipment, and others.

Service-wise, the market is segmented into skilled nursing services, rehabilitation therapy services, unskilled care services, respiratory therapy services, infusion therapy services, and pregnancy care services. Among these, the skilled nursing segment is touted to be a major services segment, projected to reach the value of USD 134166.3 million by the end of 2023. On the other hand, the segment of infusion therapy services is predicted to surge at a CAGR of 8.50% during the assessment period.

By software, the market is segmented into clinical management systems, agency software, telehealth solutions, and hospice solutions. Among these segments, the clinical management systems market is projected to lead the global market and is estimated to register a CAGR of 8.3% Competitive Analysis

The report identifies various key market players including Fresenius SE & Co KGaA (Germany), GE Healthcare (U.S.), F. Hoffmann-La Roche AG (Switzerland), Abbott (U.S.), B. Braun Melsungen AG (Germany), Koninklijke Philips N.V. (The Netherlands), 3M (U.S.), Medtronic PLC (U.S.), A&D Company (Japan), McKesson Corporation (U.S.), Kinnser Software (U.S.), Becton Dickinson Company (U.S.), Apple (U.S.), Omron Corporation (Japan), LG Electronics (South Korea), and others.

Get Home Healthcare Market Research Report, by Product (Therapeutic products, Other), Service (Skilled Nursing Services, Respiratory Therapy Service, Other), Software (Clinical Management System, Telehealth Solution, Other) — Global Forecast Till 2023 @ https://www.marketresearchfuture.com/reports/home-healthcare-market-2030

On Feb 2019, Air Liquide continued on its pursuit of developing its home healthcare activity in Europe with a big acquisition of Megamed AG and Sleep & Health SA, two historic market players who are based in Switzerland. This will help patients and healthcare professional’s needs to be addressed in a better manner.

Regional Analysis

The home healthcare market, by region, has been segmented into Americas, Europe, Asia Pacific, and the Middle East and Africa. Americas holds the major share of the global market and is poised to retain its pole position towards the end of the assessment period. The factors that are favoring the proliferation of the home healthcare market in the region include the consolidation of key players, increasing healthcare expenditure, the large-scale prevalence of chronic diseases, growing government initiatives, etc. The regional market encompasses North America and South America, out of which, North America’s home healthcare market is likely to exhibit a relatively higher growth rate over the next couple of years.

Europe has secured the second spot in the global home healthcare market. It is expected to grow substantially in the forthcoming years due to the presence of well-developed technologies and increasing support from government and private organizations for research & development.

Asia Pacific is projected to strike the highest CAGR over the assessment period. The growth-inducing factors supporting the regional home healthcare market include growing geriatric population, huge patient pool, and availability of skilled labor force. Meanwhile, the Middle East & Africa is prognosticated to account for the least share of the home healthcare market owing to the prevailing poor economic conditions, especially in the African region.

Related Report

Medical Tourism Market

Laser Therapy Market

About Market Research Future:

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:

https://www.marketresearchfuture.com